When evaluating a MOTS-c Certificate of Analysis (COA) for laboratory research, investigators must focus on las 2 cosas: precise mass spectrometry (MS) identification to confirm molecular weight and Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to verify chemical purity. Together, these two analytical pillars guarantee that the sequence integrity and purity threshold meet stringent preclinical trial requirements.
When evaluating a MOTS-c Certificate of Analysis (COA) for laboratory research, investigators must focus on las 2 cosas: precise mass spectrometry (MS) identification to confirm molecular weight and Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to verify chemical purity. Together, these two analytical pillars guarantee that the sequence integrity and purity threshold meet stringent preclinical trial requirements.
In analytical chemistry and peptide synthesis quality control, assessing a Certificate of Analysis requires isolating the core verification metrics that dictate experimental reproducibility. For mitochondrial-derived peptides like MOTS-c research peptide, researchers frequently distill quality evaluation down to 'las 2 cosas'—the two foundational analytical parameters: absolute sequence identity via Mass Spectrometry (MS) and chromatographic purity via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). Without independent, lot-specific verification of both parameters, experimental data in metabolic and cellular signaling assays risks invalidation.
A compliant Certificate of Analysis must present clear raw data for both metrics rather than summary statements. Mass spectrometry confirms that the synthesized 16-amino-acid chain (Met-R-Q-R-V-V-T-L-N-F-L-I-T-L-L-K) matches the theoretical molecular weight of 2174.7 Da, while RP-HPLC measures the relative area under the curve (AUC) to quantify residual deletion sequences or synthesis byproducts. Ensuring that an independent, ISO 17025-accredited laboratory has validated these two factors protects in vitro assays and animal models from confounding baseline anomalies.
The first of 'las 2 cosas' that every Principal Investigator must verify on a MOTS-c COA is mass spec identification. Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) is utilized to determine the exact mass-to-charge ratio (m/z) of the peptide specimen. Because synthetic peptide production involves step-wise solid-phase peptide synthesis (SPPS), incomplete coupling steps can result in truncated side products that closely resemble the target peptide in size.
A certified report from PX1 Research provides clear ESI-MS spectra illustrating the dominant observed mass peak corresponding to the theoretical target weight of 2174.7 g/mol (often recorded as [M+H]+ or multi-charged species like [M+2H]2+). Confirming mass identity rules out sequence inversion, missing residues, or chemical substitution errors prior to introducing the compound into sensitive mitochondrial gene expression or metabolic pathway protocols.
The second element of 'las 2 cosas' is the quantitative measurement of purity via RP-HPLC. While mass spectrometry confirms that the correct molecular species is present, RP-HPLC isolates and quantifies all chemical species present in the sample. Liquid chromatography separates molecules based on hydrophobicity as they pass through a C18 stationary phase under a controlled acetonitrile gradient.
On a standard PX1 Research COA, the main chromatogram illustrates a singular, sharp absorption peak corresponding to purified MOTS-c, with minimal baseline noise or secondary peaks. The integrated peak area must demonstrate a target peptide purity of 99% or greater. Residual peaks represent synthesis fragments, residual protecting groups, or oxidized species. High purity ensures that cellular responses observed in preclinical models are driven entirely by the active peptide sequence and not by chemical contaminants.
Beyond 'las 2 cosas' of identity and purity, bioburden and endotoxin testing represent vital safety parameters for cell culture and animal model applications. Bacterial endotoxins—specifically lipopolysaccharides (LPS)—can induce severe inflammatory cascades, altered mitochondrial membrane potentials, and false-positive cytokine expression in macrophage or tissue assays.
PX1 Research subjects every lot of research compounds to Chromogenic Reagent Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain below 0.1 EU/mg. This low-endotoxin standard prevents artifactual inflammatory responses during in vitro cell signaling experiments and preclinical rodent studies. Reviewing the endotoxin section of the COA is a critical step for laboratories running immunomodulatory or metabolic trials.
When designing comparative metabolic research protocols, investigators often evaluate MOTS-c alongside other mitochondrial and metabolic regulators. Understanding how analytical requirements differ across these peptide classes is essential for laboratory inventory selection.
For instance, SS-31 (Elamipretide) is a small tetrapeptide targeting cardiolipin within the inner mitochondrial membrane, whereas MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial 12S rRNA gene. Similarly, Humanin research overview addresses another mitochondrial-derived peptide involved in cytoprotective signaling, while CJC-1295 No DAC represents a synthetic secretagogue involved in systemic metabolic regulation. Each compound requires specific RP-HPLC gradient methods and mass spectrometry calibration parameters to verify lot-to-lot consistency.
A critical factor in COA evaluation is the independence and accreditation of the testing facility. Manufacturer-issued internal reports lack the unbiased rigor required for peer-reviewed publication data. PX1 Research mandates that every batch undergoes analytical testing by an independent, third-party ISO 17025-accredited laboratory located within the United States.
ISO 17025 accreditation confirms that the testing laboratory operates under validated analytical methods, calibrated instrumentation, and strict chain-of-custody protocols. Each COA published in our PX1 Research analytical hub lists the independent lab details, test date, lot number, raw chromatographic data, and mass spec printouts, providing complete traceability from synthesis to final packaging.
Maintaining the analytical purity verified on the COA requires proper laboratory handling and storage procedures upon receipt. MOTS-c is supplied as a lyophilized (freeze-dried) powder under inert atmosphere to maximize shelf stability.
Upon delivery, unopened lyophilized vials should be stored at -20°C or -80°C for long-term stability. Prior to reconstitution in a sterile laminar flow hood, allow the vial to warm to room temperature to prevent moisture condensation. For aqueous laboratory assays, reconstitute using sterile bacteriostatic water for reconstitution or sterile 0.9% sodium chloride solution. Avoid repeated freeze-thaw cycles by aliquoting reconstituted solutions into single-use polypropylene tubes before deep-freeze storage.
Preclinical studies indicate that MOTS-c plays a central role in metabolic homeostasis, cellular energy regulation, and stress response mechanisms. As a mitochondrial-derived peptide (MDP), MOTS-c translocates to the nucleus under metabolic stress, where it interacts with ARE (antioxidant response element) transcription factors to regulate nuclear gene expression.
In vitro data and rodent models suggest that MOTS-c activation promotes AMP-activated protein kinase (AMPK) phosphorylation, enhances glucose utilization, and supports metabolic flexibility. Researchers studying exercise capacity, insulin sensitivity, and age-related metabolic decline utilize high-purity MOTS-c to evaluate these cellular signaling pathways without interference from synthetic impurities. Additional comparative context can be explored within our mitochondrial research peptides analytical series.
For academic institutions, biotechnology companies, and contract research organizations (CROs), batch consistency and supply chain security are critical considerations. PX1 Research manufactures all research peptides in US-based, GMP-compliant facilities subject to stringent quality management systems.
Orders ship directly from our fulfillment centers in California and Arizona, with same-day dispatch for orders placed before cutoff times (Monday through Friday). Principal Investigators and procurement specialists seeking dedicated lot reservations or bulk volumes can coordinate through our wholesale peptide program or browse our comprehensive catalog of research peptides to align analytical documentation with active grant protocols.
What are 'las 2 cosas' to check on a MOTS-c COA?
The 'las 2 cosas' (two key things) to inspect on a MOTS-c Certificate of Analysis are Mass Spectrometry (MS) data to confirm precise molecular identity (2174.7 Da) and Reverse-Phase HPLC (RP-HPLC) chromatograms to verify high chemical purity (>99%).
Why is third-party ISO 17025 COA testing important for research peptides?
Third-party testing by an ISO 17025 accredited laboratory guarantees independent, unbiased verification of sequence identity, purity percentage, and endotoxin levels, ensuring data reproducibility in scientific studies.
What is the expected molecular weight of MOTS-c on a Mass Spec report?
The theoretical monoisotopic molecular mass of the 16-amino-acid MOTS-c peptide is approximately 2174.7 Da. The mass spectrometry report should show a primary observed peak matching this mass.
How is MOTS-c purity quantified on a Certificate of Analysis?
MOTS-c purity is measured using RP-HPLC. The peak area of MOTS-c is integrated against secondary background peaks to determine the overall percentage of active target peptide.
What endotoxin limit is acceptable for MOTS-c in cell culture research?
Preclinical grade peptides should maintain an endotoxin level below 0.1 EU/mg, measured via chromogenic LAL testing, to prevent non-specific immune activation in cell or animal models.
How should lyophilized MOTS-c be stored in the laboratory?
Unopened lyophilized MOTS-c should be stored at -20°C or -80°C in a desiccated environment. Reconstituted aliquots should be frozen to avoid enzymatic degradation and repeated freeze-thaw cycles.
What liquid media is recommended for reconstituting MOTS-c for in vitro testing?
Reconstitution is typically performed using sterile bacteriostatic water, sterile phosphate-buffered saline (PBS), or sterile 0.9% sodium chloride, depending on the requirements of the specific bioassay.
Where are PX1 Research peptides manufactured and shipped from?
All PX1 Research compounds are manufactured in USA-based facilities and shipped directly from fulfillment hubs in California and Arizona with same-day dispatch M–F.
How does MOTS-c differ analytically from SS-31 or Humanin?
While all three target mitochondrial pathways, MOTS-c is a 16-amino-acid mitochondrial-derived peptide, SS-31 is a targeted tetrapeptide, and Humanin is a larger 24-amino-acid peptide. Each requires unique HPLC separation gradients and MS calibration.
Are PX1 Research compounds suitable for clinical or human use?
No. All compounds supplied by PX1 Research are strictly for laboratory research use only (in vitro and preclinical animal research) and are not intended for human or clinical consumption.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.